VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,590,880 | -37.5% | 143,711 | -8.5% | 0.00% | 0.0% |
| Q2 2023 | $2,545,910 | -18.3% | 157,058 | -16.1% | 0.00% | 0.0% |
| Q1 2023 | $3,117,080 | +620.1% | 187,212 | +306.6% | 0.00% | – |
| Q4 2022 | $432,851 | +286.5% | 46,048 | +12.1% | 0.00% | – |
| Q3 2022 | $112,000 | -8.2% | 41,067 | -2.9% | 0.00% | – |
| Q2 2022 | $122,000 | -46.7% | 42,305 | -44.6% | 0.00% | – |
| Q1 2022 | $229,000 | -85.0% | 76,362 | -77.0% | 0.00% | – |
| Q4 2021 | $1,528,000 | -10.2% | 332,161 | +22.7% | 0.00% | -100.0% |
| Q3 2021 | $1,701,000 | +69.1% | 270,814 | +61.2% | 0.00% | – |
| Q2 2021 | $1,006,000 | -47.9% | 168,029 | -45.0% | 0.00% | -100.0% |
| Q1 2021 | $1,932,000 | +304.2% | 305,594 | +260.0% | 0.00% | – |
| Q4 2020 | $478,000 | -75.6% | 84,899 | -74.8% | 0.00% | -100.0% |
| Q3 2020 | $1,958,000 | -17.9% | 336,467 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $2,385,000 | +30.5% | 330,681 | -15.4% | 0.00% | 0.0% |
| Q1 2020 | $1,828,000 | -44.4% | 390,707 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $3,287,000 | -17.6% | 409,834 | -29.3% | 0.00% | -50.0% |
| Q3 2019 | $3,987,000 | -14.8% | 579,490 | +2.7% | 0.00% | 0.0% |
| Q2 2019 | $4,682,000 | +72.9% | 564,158 | +107.1% | 0.00% | +100.0% |
| Q1 2019 | $2,708,000 | -30.5% | 272,402 | -46.5% | 0.00% | -50.0% |
| Q4 2018 | $3,894,000 | +8.4% | 508,972 | +146.9% | 0.00% | +100.0% |
| Q3 2018 | $3,591,000 | +360.4% | 206,157 | +150.8% | 0.00% | – |
| Q2 2018 | $780,000 | +181.6% | 82,201 | +29.8% | 0.00% | – |
| Q1 2018 | $277,000 | +575.6% | 63,329 | +533.3% | 0.00% | – |
| Q4 2017 | $41,000 | +485.7% | 10,000 | +121.9% | 0.00% | – |
| Q1 2017 | $7,000 | +75.0% | 4,506 | +38.6% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 3,252 | +30.9% | 0.00% | – |
| Q1 2016 | $4,000 | -50.0% | 2,485 | +76.5% | 0.00% | – |
| Q3 2015 | $8,000 | – | 1,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |